SSA
NMTR

Schonfeld Strategic Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,480
Closed -$29K – 3291
2022
Q2 		$29K Buy
5,480
+960
+21% +$9.04K ﹤0.01% 2275
2022
Q1 		$54K Buy
4,520
+550
+14% +$7.51K ﹤0.01% 2332
2021
Q4 		$78K Buy
3,970
+2,005
+102% +$44.9K ﹤0.01% 1914
2021
Q3 		$51K Buy
+1,965
New +$46.3K ﹤0.01% 1999
2021
Q2 		– Sell
-2,863
Closed -$67K – 2436
2021
Q1 		$67K Buy
+2,863
New +$88K ﹤0.01% 1705

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Schonfeld Strategic Advisors's NMTR Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 5,480 shares — an estimated $29K sold.

Schonfeld Strategic Advisors first reported a position in NMTR in Q1 2021 and held it in 5 quarters. The position peaked at $78K in Q4 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • Schonfeld Strategic Advisors reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 5,480 9 Meters Biopharma shares in Q3 2022, an estimated $29K.
  • Schonfeld Strategic Advisors first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's 9 Meters Biopharma position peaked at $78K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.